Cogent Biosciences, Inc. (COGT) Executive Compensation
Cogent Biosciences, Inc. (COGT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: COGT
CIK: 1622229
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerThomas Feeley
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414218 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-01 | 8-K | 0001193125-26-380194 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | 4 | 0001193125-26-377001 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001950047-26-008754 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001193805-26-001082 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342695 | View SEC Doc Filr Page |
| 424B5 | 2026-08-10 | — | 424B5 | 0001193125-26-342683 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001193125-26-342393 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-341315 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001323 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002235 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296249 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267665 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267663 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267662 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267670 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267667 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267666 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-09 | 8-K | 0001193125-26-267566 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | 4 | 0001193125-26-234578 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001193805-26-000609 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001193125-26-205170 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | 8-K | 0001193125-26-205124 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001193125-26-173857 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001193125-26-173848 | View SEC Doc Filr Page |